Health In Tech Q2 2026 Earnings Call: $32.3M Contracted Revenue, $66.3M Pipeline, Reaffirms $45-50M Guidance
HIT sits 20% above its 52-week low of $0.85.
Summary
Health In Tech's Q2 2026 earnings call revealed $32.3M in contracted revenue and a $66.3M pipeline, reframing a GAAP revenue decline as a timing shift and reaffirming full-year guidance of $45-50M.
Key Events · Earnings and Guidance · HIT
-
Q2 Revenue Declines on Carrier Onboarding Timing
GAAP revenue fell 13.5% to $8.1M from $9.3M a year ago, which management attributes to a new carrier onboarding that shifted policy effective dates into future quarters, not a demand problem.
-
New Forward Metrics: $32.3M Contracted, $66.3M Pipeline
Contracted revenue totaled $32.3M for H1 2026, with $14.0M expected in H2 2026 and $1.0M in 2027. Pipeline revenue stood at $66.3M as of July 31, 2026, with $1.9M contracted and the remaining $64.4M at an expected 15-40% conversion rate.
-
Full-Year Guidance Reaffirmed at $45-50M
Management reaffirmed 2026 revenue guidance of $45M to $50M, citing contracted and pipeline revenue as providing real forward visibility.
-
Distribution Network Grows 19.9% to 933 Partners
The company ended Q2 with 933 brokers, TPAs, and agencies, up from 778 a year ago, driven by a capital-light, partner-driven model.
Analysis · HIT · Finance
Health In Tech's Q2 2026 earnings call transcript provides new forward-looking metrics that reframe the revenue decline. The company reported a GAAP revenue drop to $8.1M from $9.3M, but management attributes this to a carrier onboarding timing shift, not demand weakness. The key new disclosures are $32.3M in contracted revenue for H1 2026 and a $66.3M pipeline as of July 31, 2026, which management argues are better indicators of future revenue than the lagging GAAP figure. The company reaffirmed full-year 2026 revenue guidance of $45-50M. Distribution partners grew 19.9% YoY to 933, and the first employer group was secured under the Three-Year Rate Stabilization Program. The balance sheet shows $6.5M in cash and $11.8M in working capital. While the net loss of $2.5M and negative adjusted EBITDA of $1.3M reflect continued investment, the new contracted and pipeline metrics provide visibility into future revenue that was not previously disclosed.
At the time of this filing, HIT was trading at $1.02 on NASDAQ in the Finance sector, with a market capitalization of approximately $69.5M. The 52-week trading range was $0.85 to $4.02. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.